ACRO makes new appointment
This article was originally published in Scrip
The Association of Clinical Research Organizations (ACRO) has appointed two new member companies – Clinilabs and ReSearch Pharmaceutical Services (RPS) – as well as electing Daniel Perlman as a new representative to the board of directors. Clinilabs and RPS both join as regular members. Mr Perlman is chairman and CEO of RPS.
You may also be interested in...
Cerimon Pharmaceuticals' once-daily topical-patch formulation of the NSAID diclofenac gave significantly better average pain relief than placebo in ankle-sprain patients who carried out their daily activities in a Phase II trial, at the third day in the study.
Following a second resubmission, the Scottish Medicines Consortiumhas accepted Lilly's Alimta (pemetrexed) for restricted use within the Scottish NHS as a monotherapy for the second-line treatment of locally advanced or metastatic non-small cell lung cancer.